Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121198722 | 12119872 | 2 | F | 20160215 | 20160701 | 20160226 | 20160711 | EXP | US-PFIZER INC-2016095682 | PFIZER | 66.00 | YR | F | Y | 68.50000 | KG | 20160711 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121198722 | 12119872 | 1 | PS | CRIZOTINIB | CRIZOTINIB | 1 | Oral | 250 MG, ONCE DAILY | Y | 202570 | 250 | MG | TABLET | QD | |||||
| 121198722 | 12119872 | 2 | SS | ITRACONAZOLE. | ITRACONAZOLE | 1 | Oral | 200 MG, ONCE DAILY | 0 | 200 | MG | CAPSULE | QD | ||||||
| 121198722 | 12119872 | 3 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | 100 MG, TID | 0 | 100 | MG | TID | |||||||
| 121198722 | 12119872 | 4 | C | CARVEDILOL. | CARVEDILOL | 1 | Oral | 6.25 MG, BID | 0 | 6.25 | MG | BID | |||||||
| 121198722 | 12119872 | 5 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 40 MG, QD | 0 | 40 | MG | QD | |||||||
| 121198722 | 12119872 | 6 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | Oral | 0.1 MG, QD | 0 | .1 | MG | QD | |||||||
| 121198722 | 12119872 | 7 | C | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | Oral | 100 MG, QD | 0 | 100 | MG | QD | |||||||
| 121198722 | 12119872 | 8 | C | COLACE | DOCUSATE SODIUM | 1 | Oral | 100 MG, BID | 0 | 100 | MG | BID | |||||||
| 121198722 | 12119872 | 9 | C | FERROUS SULFATE. | FERROUS SULFATE | 1 | Oral | 65 MG, TID | 0 | 65 | MG | TID | |||||||
| 121198722 | 12119872 | 10 | C | FONDAPARINUX | FONDAPARINUX | 1 | Subcutaneous | 7.5 MG, QD | 0 | 7.5 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121198722 | 12119872 | 1 | Colon cancer |
| 121198722 | 12119872 | 3 | Hyperuricaemia |
| 121198722 | 12119872 | 4 | Hypertension |
| 121198722 | 12119872 | 5 | Swelling |
| 121198722 | 12119872 | 7 | Diabetes mellitus |
| 121198722 | 12119872 | 8 | Constipation |
| 121198722 | 12119872 | 9 | Supplementation therapy |
| 121198722 | 12119872 | 10 | Thrombosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 121198722 | 12119872 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121198722 | 12119872 | Acute kidney injury |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 121198722 | 12119872 | 1 | 20160215 | 0 | ||
| 121198722 | 12119872 | 2 | 20160105 | 0 | ||
| 121198722 | 12119872 | 3 | 20160201 | 0 | ||
| 121198722 | 12119872 | 4 | 20151214 | 0 | ||
| 121198722 | 12119872 | 5 | 20151214 | 0 | ||
| 121198722 | 12119872 | 6 | 20151214 | 0 | ||
| 121198722 | 12119872 | 7 | 20151111 | 0 | ||
| 121198722 | 12119872 | 8 | 20151111 | 0 | ||
| 121198722 | 12119872 | 9 | 20151111 | 0 | ||
| 121198722 | 12119872 | 10 | 20140415 | 0 |